2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-elicited effects on bile acid homeostasis: Alterations in biosynthesis, enterohepatic circulation, and microbial metabolism

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Fader, Kelly A ^a,b   Nault, Rance ^a,b   Zhang, Chen ^b   Kumagai, Kazuyoshi ^b   Harkema, Jack R ^b   Zacharewski, Timothy R ^a,b  

^a Michigan State University   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CHOLESTEROL; POLYCHLORINATED DIBENZODIOXIN;

ANIMAL; BACTERIAL GENE; BACTERIUM; BLOOD; C57BL MOUSE; CHEMICAL PHENOMENA; CHEMISTRY; DRUG EFFECT; ENTEROHEPATIC CIRCULATION; FECES; FEMALE; GENETICS; HOMEOSTASIS; INTESTINE ABSORPTION; LIVER; MALE; METABOLISM;

ANIMALS; BACTERIA; BILE ACIDS AND SALTS; CHOLESTEROL; ENTEROHEPATIC CIRCULATION; FECES; FEMALE; GENES, BACTERIAL; HOMEOSTASIS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; INTESTINAL ABSORPTION; LIVER; MALE; MICE, INBRED C57BL; POLYCHLORINATED DIBENZODIOXINS;

EID: 85013746177     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-05656-8     Document Type: Article

References (81)

1. Vanni, E. et al. From the metabolic syndrome to NAFLD or vice versa? Dig Liver Dis 42, 320-330, doi:10. 1016/j. dld. 2010. 01. 016 (2010).
2. Ford, E. S., Li, C. & Zhao, G. Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. J Diabetes 2, 180-193, doi:10. 1111/j. 1753-0407. 2010. 00078. x (2010).
3. Trauner, M., Arrese, M. & Wagner, M. Fatty liver and lipotoxicity. Biochim Biophys Acta 1801, 299-310, doi:10. 1016/j. bbalip. 2009. 10. 007 (2010).
4. Taylor, K. W. et al. Evaluation of the Association between Persistent Organic Pollutants (POPs) and Diabetes in Epidemiological Studies: A National Toxicology Program Workshop Review. Environ Health Perspect 121, 774-783, doi:10. 1289/ehp. 1205502 (2013).
5. Casals-Casas, C. & Desvergne, B. Endocrine disruptors: from endocrine to metabolic disruption. Annu Rev Physiol 73, 135-162, doi:10. 1146/annurev-physiol-012110-142200 (2011).
6. Grun, F. & Blumberg, B. Endocrine disrupters as obesogens. Mol Cell Endocrinol 304, 19-29, doi:10. 1016/j. mce. 2009. 02. 018 (2009).
7. Denison, M. S. & Nagy, S. R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 43, 309-334, doi:10. 1146/annurev. pharmtox. 43. 100901. 135828 (2003).
8. Hankinson, O. The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol 35, 307-340, doi:10. 1146/annurev. pa. 35. 040195. 001515 (1995).
9. Huang, G. & Elferink, C. J. A novel nonconsensus xenobiotic response element capable of mediating aryl hydrocarbon receptordependent gene expression. Mol Pharmacol 81, 338-347, doi:10. 1124/mol. 111. 075952 (2012).
10. Beischlag, T. V., Luis Morales, J., Hollingshead, B. D. & Perdew, G. H. The aryl hydrocarbon receptor complex and the control of gene expression. Crit Rev Eukaryot Gene Expr 18, 207-250 (2008).
11. Safe, S. Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). Crit Rev Toxicol 21, 51-88, doi:10. 3109/10408449009089873 (1990).
12. Denison, M. S., Soshilov, A. A., He, G., DeGroot, D. E. & Zhao, B. Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor. Toxicol Sci 124, 1-22, doi:10. 1093/toxsci/kfr218 (2011).
13. Boverhof, D. R. et al. Temporal and dose-dependent hepatic gene expression patterns in mice provide new insights into TCDDMediated hepatotoxicity. Toxicol Sci 85, 1048-1063, doi:10. 1093/toxsci/kfi162 (2005).
14. Jones, G. & Greig, J. B. Pathological-Changes in Liver of Mice Given 2, 3, 7, 8-Tetrachlorodibenzo-P-Dioxin. Experientia 31, 1315-1317, doi:10. 1007/Bf01945801 (1975).
15. Fernandez-Salguero, P. M., Hilbert, D. M., Rudikoff, S., Ward, J. M. & Gonzalez, F. J. Aryl-hydrocarbon receptor-deficient mice are resistant to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol Appl Pharmacol 140, 173-179, doi:10. 1006/taap. 1996. 0210 (1996).
16. Nault, R. et al. Dose-Dependent Metabolic Reprogramming and Differential Gene Expression in TCDD-Elicited Hepatic Fibrosis. Toxicol Sci 154, 253-266, doi:10. 1093/toxsci/kfw163 (2016).
17. Pierre, S. et al. Aryl hydrocarbon receptor-dependent induction of liver fibrosis by dioxin. Toxicol Sci 137, 114-124, doi:10. 1093/ toxsci/kft236 (2014).
18. Chiang, J. Y. Bile acid metabolism and signaling. Compr Physiol 3, 1191-1212, doi:10. 1002/cphy. c120023 (2013).
19. Copple, B. L. & Li, T. Pharmacology of bile acid receptors: Evolution of bile acids from simple detergents to complex signaling molecules. Pharmacol Res 104, 9-21, doi:10. 1016/j. phrs. 2015. 12. 007 (2016).
20. Perez, M. J. & Briz, O. Bile-acid-induced cell injury and protection. World J Gastroenterol 15, 1677-1689 (2009).
21. Allen, K., Jaeschke, H. & Copple, B. L. Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis. Am J Pathol 178, 175-186, doi:10. 1016/j. ajpath. 2010. 11. 026 (2011).
22. Brewster, D. W., Uraih, L. C. & Birnbaum, L. S. The acute toxicity of 2, 3, 4, 7, 8-pentachlorodibenzofuran (4PeCDF) in the male Fischer rat. Fundam Appl Toxicol 11, 236-249 (1988).
23. Couture, L. A., Elwell, M. R. & Birnbaum, L. S. Dioxin-like effects observed in male rats following exposure to octachlorodibenzop-dioxin (OCDD) during a 13-week study. Toxicol Appl Pharmacol 93, 31-46 (1988).
24. Yang, K. H., Croft, W. A. & Peterson, R. E. Effects of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin on plasma disappearance and biliary excretion of foreign compounds in rats. Toxicol Appl Pharmacol 40, 485-496 (1977).
25. Vos, J. G., Moore, J. A. & Zinkl, J. G. Toxicity of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) in C57B1/6 mice. Toxicol Appl Pharmacol 29, 229-241 (1974).
26. Fletcher, N. et al. 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the mRNA expression of critical genes associated with cholesterol metabolism, bile acid biosynthesis, and bile transport in rat liver: a microarray study. Toxicol Appl Pharmacol 207, 1-24, doi:10. 1016/j. taap. 2004. 12. 003 (2005).
27. Ozeki, J. et al. Aryl hydrocarbon receptor ligand 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin enhances liver damage in bile duct-ligated mice. Toxicology 280, 10-17, doi:10. 1016/j. tox. 2010. 11. 003 (2011).
28. Sato, H. et al. Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies. J Med Chem 51, 1831-1841, doi:10. 1021/jm7015864 (2008).
29. Reich, M. et al. TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro. Gut 65, 487-501, doi:10. 1136/gutjnl-2015-309458 (2016).
30. Birnbaum, L. S., McDonald, M. M., Blair, P. C., Clark, A. M. & Harris, M. W. Differential toxicity of 2, 3, 7, 8-tetrachlorodibenzo-pdioxin (TCDD) in C57BL/6J mice congenic at the Ah Locus. Fundam Appl Toxicol 15, 186-200 (1990).
31. McConnell, E. E., Moore, J. A., Haseman, J. K. & Harris, M. W. The comparative toxicity of chlorinated dibenzo-p-dioxins in mice and guinea pigs. Toxicol Appl Pharmacol 44, 335-356 (1978).
32. Fader, K. A. et al. 2, 3, 7, 8-Tetrachlorodibenzo-p-Dioxin Alters Lipid Metabolism and Depletes Immune Cell Populations in the Jejunum of C57BL/6 Mice. Toxicol Sci 148, 567-580, doi:10. 1093/toxsci/kfv206 (2015).
33. Fader, K. A. et al. Convergence of hepcidin deficiency, systemic iron overloading, heme accumulation, and REV-ERBalpha/beta activation in aryl hydrocarbon receptor-elicited hepatotoxicity. Toxicol Appl Pharmacol 321, 1-17, doi:10. 1016/j. taap. 2017. 02. 006 (2017).
34. Nault, R., Fader, K. A., Lydic, T. A. & Zacharewski, T. R. Lipidomic Evaluation of Aryl Hydrocarbon Receptor-Mediated Hepatic Steatosis in Male and Female Mice Elicited by 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin. Chem Res Toxicol 30, 1060-1075, doi:10. 1021/ acs. chemrestox. 6b00430 (2017).
35. Botham, K. M. & Boyd, G. S. The metabolism of chenodeoxycholic acid to beta-muricholic acid in rat liver. Eur J Biochem 134, 191-196 (1983).
36. Nault, R. et al. Pyruvate Kinase Isoform Switching and Hepatic Metabolic Reprogramming by the Environmental Contaminant 2, 3, 7, 8-Tetrachlorodibenzo-p-Dioxin. Toxicol Sci 149, 358-371, doi:10. 1093/toxsci/kfv245 (2016).
37. Sayin, S. I. et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 17, 225-235, doi:10. 1016/j. cmet. 2013. 01. 003 (2013).
38. Billington, D., Evans, C. E., Godfrey, P. P. & Coleman, R. Effects of bile salts on the plasma membranes of isolated rat hepatocytes. Biochem J 188, 321-327 (1980).
39. Palmer, R. H. Bile acids, liver injury, and liver disease. Arch Intern Med 130, 606-617 (1972).
40. Hofmann, A. F. & Roda, A. Physicochemical properties of bile acids and their relationship to biological properties: an overview of the problem. J Lipid Res 25, 1477-1489 (1984).
41. Heuman, D. M. Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J Lipid Res 30, 719-730 (1989).
42. Araya, Z. & Wikvall, K. 6alpha-hydroxylation of taurochenodeoxycholic acid and lithocholic acid by CYP3A4 in human liver microsomes. Biochim Biophys Acta 1438, 47-54 (1999).
43. Xie, W. et al. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc Natl Acad Sci USA 98, 3375-3380, doi:10. 1073/pnas. 051014398 (2001).
44. Meier, P. J. & Stieger, B. Bile salt transporters. Annu Rev Physiol 64, 635-661, doi:10. 1146/annurev. physiol. 64. 082201. 100300 (2002).
45. Csanaky, I. L. et al. Organic anion-transporting polypeptide 1b2 (Oatp1b2) is important for the hepatic uptake of unconjugated bile acids: Studies in Oatp1b2-null mice. Hepatology 53, 272-281, doi:10. 1002/hep. 23984 (2011).
46. Gérard, P. Metabolism of Cholesterol and Bile Acids by the Gut Microbiota. Pathogens 3, 14-24, doi:10. 3390/pathogens3010014 (2014).
47. Ridlon, J. M. & Hylemon, P. B. Identification and characterization of two bile acid coenzyme A transferases from Clostridium scindens, a bile acid 7alpha-dehydroxylating intestinal bacterium. J Lipid Res 53, 66-76, doi:10. 1194/jlr. M020313 (2012).
48. Wells, J. E., Williams, K. B., Whitehead, T. R., Heuman, D. M. & Hylemon, P. B. Development and application of a polymerase chain reaction assay for the detection and enumeration of bile acid 7alpha-dehydroxylating bacteria in human feces. Clin Chim Acta 331, 127-134 (2003).
49. Ou, J. et al. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am J Clin Nutr 98, 111-120, doi:10. 3945/ajcn. 112. 056689 (2013).
50. Lefever, D. E. et al. TCDD modulation of gut microbiome correlated with liver and immune toxicity in streptozotocin (STZ)-induced hyperglycemic mice. Toxicol Appl Pharmacol 304, 48-58, doi:10. 1016/j. taap. 2016. 05. 016 (2016).
51. Zhang, L. et al. Persistent Organic Pollutants Modify Gut Microbiota-Host Metabolic Homeostasis in Mice Through Aryl Hydrocarbon Receptor Activation. Environ Health Perspect 123, 679-688, doi:10. 1289/ehp. 1409055 (2015).
52. Kakizuka, S. et al. Dioxin-Produced Alteration in the Profiles of Fecal and Urinary Metabolomes: A Change in Bile Acids and Its Relevance to Toxicity. Biol Pharm Bull 38, 1484-1495, doi:10. 1248/bpb. b15-00235 (2015).
53. Wahlstrom, A., Sayin, S. I., Marschall, H. U. & Backhed, F. Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism. Cell Metab 24, 41-50, doi:10. 1016/j. cmet. 2016. 05. 005 (2016).
54. Gao, X. et al. The antiandrogen flutamide is a novel aryl hydrocarbon receptor ligand that disrupts bile acid homeostasis in mice through induction of Abcc4. Biochem Pharmacol, doi:10. 1016/j. bcp. 2016. 08. 021 (2016).
55. Iwanaga, T., Nakakariya, M., Yabuuchi, H., Maeda, T. & Tamai, I. Involvement of bile salt export pump in flutamide-induced cholestatic hepatitis. Biol Pharm Bull 30, 739-744 (2007).
56. Javitt, N. B. & Emerman, S. Effect of sodium taurolithocholate on bile flow and bile acid exeretion. J Clin Invest 47, 1002-1014, doi:10. 1172/JCI105790 (1968).
57. Beuers, U. et al. Taurolithocholic acid exerts cholestatic effects via phosphatidylinositol 3-kinase-dependent mechanisms in perfused rat livers and rat hepatocyte couplets. J Biol Chem 278, 17810-17818, doi:10. 1074/jbc. M209898200 (2003).
58. Gonzalez, F. J. & Fernandez-Salguero, P. The aryl hydrocarbon receptor: studies using the AHR-null mice. Drug Metab Dispos 26, 1194-1198 (1998).
59. Angrish, M. M., Dominici, C. Y. & Zacharewski, T. R. TCDD-elicited effects on liver, serum, and adipose lipid composition in C57BL/6 mice. Toxicol Sci 131, 108-115, doi:10. 1093/toxsci/kfs277 (2013).
60. Sorg, O. et al. 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) poisoning in Victor Yushchenko: identification and measurement of TCDD metabolites. Lancet 374, 1179-1185, doi:10. 1016/S0140-6736(09)60912-0 (2009).
61. Wolfe, W. H. et al. Determinants of TCDD half-life in veterans of operation ranch hand. J Toxicol Environ Health 41, 481-488, doi:10. 1080/15287399409531858 (1994).
62. Gasiewicz, T. A., Geiger, L. E., Rucci, G. & Neal, R. A. Distribution, excretion, and metabolism of 2, 3, 7, 8-tetrachlorodibenzo-pdioxin in C57BL/6J, DBA/2J, and B6D2F1/J mice. Drug Metab Dispos 11, 397-403 (1983).
63. Everson, G. T., Braverman, D. Z., Johnson, M. L. & Kern, F. Jr. A critical evaluation of real-time ultrasonography for the study of gallbladder volume and contraction. Gastroenterology 79, 40-46 (1980).
64. Wang, H. H. et al. Effect of gallbladder hypomotility on cholesterol crystallization and growth in CCK-deficient mice. Biochim Biophys Acta 1801, 138-146, doi:10. 1016/j. bbalip. 2009. 10. 003 (2010).
65. Kopec, A. K. et al. PCB153-elicited hepatic responses in the immature, ovariectomized C57BL/6 mice: comparative toxicogenomic effects of dioxin and non-dioxin-like ligands. Toxicol Appl Pharmacol 243, 359-371, doi:10. 1016/j. taap. 2009. 12. 003 (2010).
66. Nault, R., Colbry, D., Brandenberger, C., Harkema, J. R. & Zacharewski, T. R. Development of a computational high-throughput tool for the quantitative examination of dose-dependent histological features. Toxicol Pathol 43, 366-375, doi:10. 1177/0192623314544379 (2015).
67. Nault, R., Fader, K. A. & Zacharewski, T. RNA-Seq versus oligonucleotide array assessment of dose-dependent TCDD-elicited hepatic gene expression in mice. BMC Genomics 16, 373, doi:10. 1186/s12864-015-1527-z (2015).
68. Burgoon, L. D. & Zacharewski, T. R. Automated quantitative dose-response modeling and point of departure determination for large toxicogenomic and high-throughput screening data sets. Toxicol Sci 104, 412-418, doi:10. 1093/toxsci/kfn083 (2008).
69. Yang, L., Allen, B. C. & Thomas, R. S. BMDExpress: a software tool for the benchmark dose analyses of genomic data. BMC Genomics 8, 387, doi:10. 1186/1471-2164-8-387 (2007).
70. Lo, R. & Matthews, J. High-resolution genome-wide mapping of AHR and ARNT binding sites by ChIP-Seq. Toxicol Sci 130, 349-361, doi:10. 1093/toxsci/kfs253 (2012).
71. Ji, H. et al. An integrated software system for analyzing ChIP-chip and ChIP-seq data. Nat Biotechnol 26, 1293-1300, doi:10. 1038/ nbt. 1505 (2008).
72. John, C. et al. A liquid chromatography-tandem mass spectrometry-based method for the simultaneous determination of hydroxy sterols and bile acids. J Chromatogr A 1371, 184-195, doi:10. 1016/j. chroma. 2014. 10. 064 (2014).
73. Swann, J. R. et al. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc Natl Acad Sci USA 108(Suppl 1), 4523-4530, doi:10. 1073/pnas. 1006734107 (2011).
74. Lydic, T. A., Busik, J. V. & Reid, G. E. A monophasic extraction strategy for the simultaneous lipidome analysis of polar and nonpolar retina lipids. J Lipid Res 55, 1797-1809, doi:10. 1194/jlr. D050302 (2014).
75. Melamud, E., Vastag, L. & Rabinowitz, J. D. Metabolomic analysis and visualization engine for LC-MS data. Anal Chem 82, 9818-9826, doi:10. 1021/ac1021166 (2010).
76. Haimi, P., Uphoff, A., Hermansson, M. & Somerharju, P. Software tools for analysis of mass spectrometric lipidome data. Anal Chem 78, 8324-8331, doi:10. 1021/ac061390w (2006).
77. Kessner, D., Chambers, M., Burke, R., Agus, D. & Mallick, P. ProteoWizard: open source software for rapid proteomics tools development. Bioinformatics 24, 2534-2536, doi:10. 1093/bioinformatics/btn323 (2008).
78. Arrieta, M. C., Bistritz, L. & Meddings, J. B. Alterations in intestinal permeability. Gut 55, 1512-1520, doi:10. 1136/gut. 2005. 085373 (2006).
79. Teshima, C. W. & Meddings, J. B. The measurement and clinical significance of intestinal permeability. Curr Gastroenterol Rep 10, 443-449 (2008).
80. Fish, J. A. et al. FunGene: the functional gene pipeline and repository. Front Microbiol 4, 291, doi:10. 3389/fmicb. 2013. 00291 (2013).
81. Muyzer, G., de Waal, E. C. & Uitterlinden, A. G. Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl Environ Microbiol 59, 695-700 (1993).